High frequency of premature termination mutations in the factorV gene: Three factorV deficiency case reports and a mutation review

Iris Schrijver; Debbie W. Hong; Lisa Mandle; Carol D. Jones; Donna Di Michele; Paul E. Monahan; James L. Zehnder

doi:10.1055/s-0037-1616566

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2005; 93(03): 610-611
DOI: 10.1055/s-0037-1616566

Case Report

Schattauer GmbH

High frequency of premature termination mutations in the factorV gene: Three factorV deficiency case reports and a mutation review

Authors

Iris Schrijver

¹Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
Debbie W. Hong

¹Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
Lisa Mandle

¹Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
Carol D. Jones

¹Department of Pathology, Stanford University School of Medicine, Stanford, California, USA
Donna Di Michele

²Weill Medical College of Cornell University, New York, New York, USA
Paul E. Monahan

³Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, Noth Carolina, USA
James L. Zehnder

¹Department of Pathology, Stanford University School of Medicine, Stanford, California, USA

Abstract

Volltext

Referenzen

References
1 Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31: 3777-85.
2 Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20-30.
3 Montefusco MC, Duga S, Asselta R. et al. Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations. Blood 2003; 102: 3210-6.
4 Seeler RA. Parahemophilia. Factor V deficiency. Med Clin North Am 1972; 56: 119-25.
5 Schrijver I, Houissa-Kastally R, Jones CD. et al. Novel factor V C2-domain mutation (R2074H) in two families with factor V deficiency and bleeding. Thromb Haemost 2002; 87: 294-9.
6 Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999; 82: 1207-14.
7 Acharya SS, Coughlin A, Dimichele DM. North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-56.
8 Frishmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999; 8: 1893-900.
9 Culbertson MR. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders, and cancer. Trends Genet 1999; 15: 74-80.
10 Lunghi B, Castoldi E, Mingozzi F. et al. A novel Factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject. Blood 1998; 92: 1463-4.
11 Kitzis A, Salmeron S, Chomel JC. et al. Gene symbol: F5. Disease: Factor V deficiency. Hum Genet 1999; 104: 290
12 Mirochnik O, Halim-Kertanegara N, Henniker AJ. et al. A novel factor V null mutation at Arg506 causes a false positive Factor V Leiden result. Thromb Haemost 1999; 82: 1198-9.
13 van Wijk R, Nieuwenhuis HK, van den Berg HM. et al. Five novel mutations in the gene for coagulation factor V associated with type I factor V deficiency. Blood 2001; 98: 358-67.
14 van Wijk R, Montefusco MC, Duga S. et al. Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency. Br J Haematol 2001; 114: 871-4.
15 Mumford AD, McVey JH, Morse CV. et al. Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol 2003; 123: 496-501.
16 Castoldi E, Kalafatis M, Lunghi B. et al. Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost 1998; 80: 403-6.
17 Guasch JF, Cannegieter S, Reitsma PH. et al. Severe coagulation factor V deficiency caused by a 4 bp deletion in the Factor V gene. Br J Haematol 1998; 101: 32-9.
18 Zehnder JL, Hiraki DD, Jones CD. et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the Factor V gene: Factor V Stanford. Thromb Haemost 1999; 82: 1097-9.
19 Montefusco MC, Asselta R, van Wijk R. et al. Concerns about the mutations identified in a case of familial coagulation factor V deficency: factor V Stanford. Throm Haemost 2000; 84: 1131-2.
20 Montefusco MC, Duga S, Asselta R. et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol 2000; 111: 1240-6.
21 Howard J, Hughes RG, Basu S. et al. A novel mutation in the Factor V gene causing a severe coagulation defect in two sisters. Blood 2000; 96: 642a (Abstract #2759)
22 Ajzner E, Balogh I, Szabo T. et al. Severe coagulation Factor V deficiency caused by 2 novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene. Blood 2002; 99: 702-5.
23 Hou LH, Xie F, Liu XE. et al. A novel mutation causes congenital factor V deficiency. Zhonghua Xue Ye Xue Za Zhi 2003; 24: 455-9.
24 Fu Q, Wu W, Ding Q. et al. Type I coagulation deficiency caused by compound heterozygous mutation of F5 gene. Haemophilia 2003; 9: 646-9.
25 Dargaud Y, Trzeciak MC, Meunier S. et al. Two novel Factor V null mutations associated with activated protein C resistance phenotype/genotype discrepancy. Br J Haematol 2003; 123: 342-5.
26 Fu QH, Zhou RF, Liu LG. et al. Identification of three F5 gene mutations associated with inherited coagulation factor V deficiency in two Chinese pedigrees. Haemophilia 2004; 10: 264-70.
27 Schrijver I, Koerper M, Jones CD. et al. Homozygous factor V splice site mutation associated with severe factor V deficiency. Blood 2002; 99: 3063-5.